"tVNS therapy in Comatose Patients"  has been a focus research area in recent years in collaboration with esteemed scientists from various countries. The Coma Symposium brought together notable experts, including Prof. Dr. Halil Özcan, Head of the Psychiatry Department at Erzurum Atatürk University, Prof. Dr. Arshad Majid, Head of Neuroscience and Cerebrovascular Neurology at the University of Sheffield, UK, Prof. Armin Bolz, the scientist who has been developing of the patented tVNS technology from Germany, and Selin Erdoğan Gezen, Global Clinical Director at tVNS Health Gmbh. The symposium hosted the discussions on the use of tVNS in comatose patients, sharing clinical experiences, and exploring the future of this therapy. The meeting was held on November 14-15th, under the organization of the Akogo Foundation, committed to providing care at the highest international standards, employing advanced diagnostic tools and neurorehabilitation techniques, in two dedicated "Alarm Clock" Clinics, the first rehabilitation centers for children and adults, in Poland. The event was a highly productive scientific meeting where the use of tVNS in comatose patients across different countries was discussed, patient grou ps who has the potential to benefit from the therapy were identified, and future scientific collaborations and studies were initiated. Sessions also featured case reports from Turkey by esteemed doctors Assoc. Prof. Dr. Burcu Polat and Prof. Dr. Ercan Gürses , highlighting treatments applied to hypoxic patients. These sessions provided inspiration for future treatment protocols. In the coming days, we look forward to sharing the results of a clinical study on the application of tVNS therapy, with the hope that it will inspire and bring new possibilities. We remain committed to offering hope to patients considered untreatable through non-invasive, scientifically supported therapies. Our deepest gratitude goes to our esteemed doctors and scientists for their invaluable contributions to these efforts. A special thank you to Fundacja Ewy Błaszczyk Akogo? for hosting this impactful event and fostering collaboration to advance pediatric care. Together, we’re working towards brighter possibilities. Source: https://www.akogo.pl/pl/aktualnosci/budzik-dla-dzieci/nauka-nie-spi #coma #tvns #vagusnerve #vagusnervestimulation #vnstherapy #vagusnerve #comatose #akogo #stroke #stroketreatment

Zeliha Korkmaz, the mother of 7-year-old Oğuzhan, who battles resistant epilepsy and was diagnosed with Dravet syndrome at 4.5 months old, recently shared their transformative journey with tVNS. Oğuzhan endured numerous hospitalizations due to refractory seizures, even undergoing a ketogenic diet that eventually proved ineffective. Following his physician's recommendation, Oğuzhan began using tVNS in January 2022. Since then, the positive impact on his life has been remarkable — experiencing extended seizure-free periods, enhanced cognitive abilities, and an overall improved quality of life. At tVNS, we strive to contribute to a better world for human life by evolving treatments to meet the changing needs of our dynamic world.

The "tVNS Special Issue", has been published in the "Journal Autonomic Neuroscience", the official journal of the International Society for Autonomic Neuroscience, published by Elsevier. We are proud to design the future of neuroscience and to be the pioneer of the medical technologies. Below are the titles of the tVNS Clinical Studies and articles in the journal. Link is below: 1. tVNS in the treatment of drug-resistant epilepsy 2. Cardiovascular responses to low-level transcutaneous vagus nerve stimulation 3. Electrical vagus nerve stimulation as a prophylaxis for SIRS and postoperative ileus 4. tVNS as a potential therapeutic application for neurodegenerative disorders – A focus on dysautonomia in Parkinson's disease 5. tVNS in the management of headache and pain 6. Brain plasticity and vagus nerve stimulation 7. tVNS for the treatment of postural tachycardia syndrome 8. Functional anatomy of the vagus system – Emphasis on the somato-visceral interface 9. Effects of tVNS on cardiovascular autonomic control in health and disease 10. tVNS and heart rate variability: Analysis of parameters and targets 11. Current challenges in reliably targeting the noradrenergic locus coeruleus using transcutaneous auricular vagus nerve stimulation (taVNS) 12. The LC-NE system as a potential target for neuromodulation to ameliorate non-motor symptoms in Parkinson's disease 13. Vagus nerve afferent stimulation: Projection into the brain, reflexive physiological, perceptual, and behavioral responses, and clinical relevance 14. Transcutaneous vagus nerve stimulation (tVNS) in stroke: the evidence, challenges and future directions 15. t-VNS to treat disorders of behaviour in Prader-Willi Syndrome and in people with other neurodevelopmental conditions 16. Technical aspects and future approaches in transcutaneous vagus nerve stimulation (tVNS) 17. A two-week course of transcutaneous vagal nerve stimulation improves global sleep: Findings from a randomised trial in community-dwelling adults https://www.sciencedirect.com/journal/autonomic-neuroscience/special-issue/10DBND1B8HC

tVNS SharePoint tVNS General Brochure General information about tVNS Download tVNS Brochure tVNS Introductory Presentation Learn more about tVNS Download tVNS Presentation tVNS in Epilepsy tVNS Epilepsy brochure with indication specific information and clinical studies. Clinical Trials and Studies For further information and clinical trials, click the button Check our Clinical Studies Page Download tVNS Brochure for Epilepsy Download tVNS Brochure for Autism tVNS in Autism tVNS Autism brochure with indication specific information and clinical studies.

tVNS® vagus therapy devices offer a non-surgical neuromodulation treatment option by providing auricular vagus nerve stimulation in difficult-to-treat brain diseases with the help of a smartphone-sized device and a special electrode. tVNS® Devices for Patients Be a part of your success story Buy tVNS tVNS Patient Devices - tVNS E tVNS® vagus therapy devices offer a non-surgical neuromodulation treatment option by providing auricular vagus nerve stimulation in difficult-to-treat brain diseases with the help of a smartphone-sized device and a special electrode. With its innovative mobile application, the patient can share all the treatment information with a single click without leaving his home, and reach the necessary follow-up and support. tVNS® stimulates the branch of the vagus nerve in the auricle through the skin with gentle electrical impulses. Signals are passed on to the brain via special nerve fibers: first in the brain stem and then in higher centers. The treatment with tVNS® is applied by patients independently. It has been used by thousands of patients and is a treatment with very few side effects. Developed and manufactured in Germany, our devices meet the highest quality standards, reflecting our dedication to excellence and the well-being of our patients tVNS® is approved for the treatment of the following indications. Anxiety Atrial Fibrillation Autism Cognitive Impairment Crohn's disease (IBD) Depression Epilepsy Migraine Parkinson's Prader-Willi Syndrome Sleeping disorders Systematic Sclerosis Tinnitus Non-Surgical Treatment t VNS-L ® offers vagus treatment option in full patient control, which does not require surgery and does not involve invasive risks. Remote Delivery Device delivery, regular follow-up and any update on the therapy are possible remotely without leaving your home. Minimal Side Effects tVNS® has minimal side effects compared to drug treatments and invasive treatmens. Innovative Technology With the tVNS® Patient application, you can follow your treatment and share it with your doctor remotely. More Flexibility Pacemaker, cerebral shunt, cardiovascular and respiratory diseases are not barriers to try tVNS therapy Pediatric Flexibility Approved for children aged 3 and over, can be used from a doctor-approved newborn as there is no invasive intervention Customized Therapy tVNS ® is a personalized therapy that can be customized according to the patient's life routines and symptoms. Easy to Use tVNS® is easy to use, as small as a smartphone and perfectly suited for everyday life. More Controlled Life It can significantly reduce or eliminate symptoms. in this way can provide a more controlled life How does tVNS® work? With tVNS® ①, light electrical stimulation ④ is given to the vagus nerve ② in the ear ③. These signals are special nerve fibers in the brain stem ⑤ before and then transmitted to the brain via the respective control centers. These stimuli cause the release of neurotransmitters from the brain and increase parasympathetic activity. Treatment with tVNS® is applied by the patient himself. It can be easily integrated into daily life. The tVNS Health Services For Patients W e offer you a bundle of services including: Device training Access to doctors all over the world with transcutaneous vagus nerve stimulation experience Therapy tracking to help an accurate usage of the device to help you get the maximum benefit

Excessive drug use in children can cause developmental delay. tVNS provides long-term positive results by reducing the need for drug use. tVNS is safe for children and approved for pediatric use. tVNS provides benefits in mental development and motor development. Use of tVNS® in Children tVNS is safe for children and MDR CE approved for pediatric use Epilepsy, Autism, Prader Willy Syndrom are the approved indications Young children should use the device under parental supervision. Excessive drug use in children can cause developmental delay. tVNS provides long-term positive results by reducing the need for drug use. Reducing drug use helps prevent the side effects of anti-epileptic drugs Improves energy, concentration, and mood Children who are using the therapy in the long term can experience cognitive and motor improvement